Psoriasis
National Psoriasis Foundation to honor leaders at 2025 Commit to Cure Gala
The National Psoriasis Foundation has announced the honorees for this year’s Commit to Cure Gala, according to a press release.
Swiping Away Comorbidities Through the Lens of Psoriatic Disease
This activity is supported by educational grants from Amgen and Lilly.
Veterans experience higher rates of skin cancer, psoriasis than nonveterans
Veterans experience higher prevalence rates of skin cancer, especially melanoma, and psoriasis compared with nonveterans, according to a study.
Secukinumab demonstrates efficacy for psoriasis in patients with skin of color
Secukinumab was shown to be safe and efficacious in treating psoriasis in patients with skin of color, according to a study.
Oral zasocitinib presents high potential as new psoriasis treatment
Zasocitinib, a potent and selective tyrosine kinase 2 inhibitor, safely and effectively cleared psoriasis in a high proportion of patients, according to a study.
Otezla available in US for treatment of plaque psoriasis in children, adolescents
Otezla is now available in the U.S. for the treatment of moderate to severe plaque psoriasis in children and adolescents aged 6 years and older, Amgen announced in a press release.
Disease severity associated with work absenteeism in psoriasis patients
Individuals with moderate to severe psoriasis experience work absenteeism more than those with a mild form of the disease, according to a study.
Guselkumab demonstrates long-term efficacy, safety in psoriasis
Guselkumab can effectively and safely treat patients with psoriasis for up to 2 years, according to a study.
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of August 19, 2024
In this edition, drug discounts through Medicare price negotiations, opioid use has fallen 15% annually since 2014 and more.
Cal/BDP cream preferred over foam formulation among patients with psoriasis
Calcipotriol/betamethasone dipropionate, or CAL/BDP, combination cream vs. foam had higher satisfaction ratings among patients with psoriasis, suggesting the cream formulation may increase adherence, according to a study.